CD177 and colorectal carcinoma: SCFAs have been detected in higher levels in healthy individuals in comparison to CRC patients, and have been shown to inhibit histone deacetylase activity and interact with cell surface receptors in enterocytes affecting the epigenetic gene expression [72].